Drug profile · INN
methantheline bromide
BANTHINE
methantheline bromide (BANTHINE) is a histamine h2 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — methantheline bromide
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
methantheline bromide (BANTHINE) is a histamine h2 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Histamine H2 receptor antagonist
Primary target: Histamine H2 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is methantheline bromide?
methantheline bromide (BANTHINE) is a histamine h2 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for methantheline bromide?
BANTHINE is a marketed brand name for methantheline bromide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of methantheline bromide?
methantheline bromide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.